drugset / Trial / NCT06810869
Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Stable Vitiligo
Phase 0
Not yet recruiting
29 enrolled
Second Affiliated Hospital of Wannan Medical College
Guidon Pharmaceutics Ltd. · collab
RandomizedSequentialQuadruple-blindTreatment
Summary
Evaluate the efficacy of induced pluripotent stem cell-derived exosomes (iPSC-Exos) for the treatment of stable vitiligo
Timeline
- Start
- 2025-02-05
- Primary completion
- 2026-11-17
- Completion
- 2026-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GD-iExo-003 | Other / unclassified | 1e+08 unknown | Other |
| Subject | GD-iExo-003 | Other / unclassified | 3e+08 unknown | Other |
| Subject | GD-iExo-003 | Other / unclassified | 9e+08 unknown | Other |